In conclusion, the characterization of the role of histamine, H4R receptor and GILZ could pave the way for innovative therapies for various chronic inflammatory diseases (allergy, asthma, chronic itch, intestinal disorders) and autoimmune diseases (arthritis. This evidence concerns the gene TSC22D3 and intestinal disorder.